US GAO/CMS threat for pharmacists

29 January 2007

An analysis dated December 22, 2006, yet only released publicly on January 23 by the US Government Accountability Office, reveals that a new formula for reimbursing pharmacies that serve Medicaid recipients will result in pharmacists losing, on average, 36% on every Medicaid prescription they fill.

"The Centers for Medicare and Medicaid Services (CMS) is effectively putting community pharmacies out of the Medicaid business," said National Community Pharmacists Association chief executive Bruce Roberts. "It will be the nation's poor - in particular women and children who make up the majority of Medicaid recipients - who will suffer when they no longer have access to community pharmacies for the medicines they need," he added.

Continued reimbursement cuts in both Medicaid and the Medicare Part D program are threatening the existence of many independent community pharmacies. In many rural areas, the local independent is the only pharmacy serving the community, and this new reimbursement is a threat to its viability, presenting a real health crisis for local citizens. "In Indiana, for example," said Mr Roberts, "more than 6% of community pharmacies went out of business due to continually declining reimbursement. With this new Medicaid reimbursement cut, many more will suffer the same fate."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight